Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis. [Phase 2]
A Phase 2 trial using 31P-MRS imaging to evaluate CNM-Au8's effects on impaired neuronal redox state in people with Multiple Sclerosis has c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Disease Progression in ms
A not-yet-recruiting clinical trial led by Hüseyin Bektaş aims to predict disease progression in multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis [NA]
This clinical trial update notes ongoing recruitment for a study assessing motor learning to improve fall resistance in relapsing-remitting …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Walking Fatigability and Brain Activity in People With Multiple Sclerosis
Clinical trial update from Hasselt University on walking fatigability and brain activity in people with Multiple Sclerosis; the study is cur…
-
FDA approval · 2025-12-16FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental abbreviated new drug application for tizanidine hydrochloride (generic tizanidine).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases [EARLY_Phase 1]
A Phase 1 trial evaluating a universal CAR T-cell therapy targeting CD19 and BCMA in relapsed/refractory neurological autoimmune diseases, w…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Smart Wearable Device (gaitQ): Walk Better Project
A smart wearable gaitQ device is being studied in the Walk Better Project and is currently recruiting participants for a trial addressing ga…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis
A prospective longitudinal study evaluating the Syde digital endpoint in patients with Multiple Sclerosis has been terminated.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: TRAIN-BW: Backward Walking Training in Multiple Sclerosis [NA]
This clinical trial update reports on TRAIN-BW, a Wayne State University study evaluating backward walking training for gait impairment in p…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
This clinical trial is a multicenter retrospective observational study evaluating the clinical impact of AI-assisted MRI care in multiple sc…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy [Phase 2]
Phase IIa randomized, double-blind, placebo-controlled trial completed to evaluate whether the combination of metformin and clemastine can p…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Design and Validation of Innovative Strategies Based on Dual-Task Approach [NA]
A clinical trial update describing the design and validation of innovative dual-task strategies, with conditions including stroke, multiple …
-
EMA approval · 2025-12-11EMA Authorised: Teriflunomide Viatris (previously Teriflunomide Mylan) (teriflunomide) — Viatris Limited
The EMA authorised Teriflunomide Viatris for treatment of relapsing-relapsing multiple sclerosis, with Viatris Limited as the marketing auth…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère [NA]
A completed clinical trial update (NCT03339817) from INSERM France describing respiratory disorders observed in patients with severe multipl…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Effect of Hydrotherapy on Multiple Sclerosis [NA]
This clinical trial update notes the completion of a study evaluating hydrotherapy for multiple sclerosis. No results are provided in the sn…
-
EMA approval · 2025-12-09EMA Authorised: Aubagio (teriflunomide) — Sanofi Winthrop Industrie
The EMA authorised Aubagio (teriflunomide) for multiple sclerosis, with Sanofi Winthrop Industrie listed as the marketing authorisation hold…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
This clinical trial studies multimodal imaging to uncover the biological mechanisms underlying neurodegeneration in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Psychological Interventions for Multiple Sclerosis: Effects on Anxiety, Depression, and Cognition. [NA]
Completed clinical trial evaluating psychological interventions, including cognitive-behavioral therapy, for people with relapsing-remitting…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Autonomic Dysfunction in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis : A Comparative Study
This clinical trial update describes a study comparing autonomic dysfunction in neuromyelitis optica spectrum disorder and multiple sclerosi…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study [NA]
This is an update on an ongoing prospective multi-center study evaluating AI-assisted care for people with multiple sclerosis and related co…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Home-based Action Observation Treatment With Virtual-reality for Arm Rehabilitation in People With Multiple Sclerosis [NA]
This entry reports a clinical trial evaluating home-based action observation therapy with virtual reality to aid arm rehabilitation in peopl…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Senolytics for Secondary Progressive MS [Phase 1]
A Phase 1 clinical trial evaluating senolytic therapies for secondary progressive multiple sclerosis, sponsored by Ohio State University; th…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Cladribine Tablets After Treatment With Natalizumab (CLADRINA) [Phase 4]
Phase 4 clinical trial evaluating cladribine tablets after natalizumab therapy in multiple sclerosis; the study is currently active but not …
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Effects of Home-based Respiratory Muscle Training With New Load Adjustment Test in People With Multiple Sclerosis [NA]
Clinical trial update on a home-based respiratory muscle training regimen with a new load adjustment test for people with multiple sclerosis…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Effects of Lower Extremity Neuromuscular Facilitation and Patients With Multiple Sclerosis [NA]
A completed clinical trial evaluating lower extremity neuromuscular facilitation in people with multiple sclerosis, focusing on gait, balanc…